Pacific Biosciences of California, Inc. Deferred Tax Assets, Operating Loss Carryforwards, Domestic
Pacific Biosciences of California, Inc. (PACB) had Deferred Tax Assets, Operating Loss Carryforwards, Domestic of $6.00 million as of 2017-12-31, per its 10-K filed 2018-02-26.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net › Deferred Tax Assets, Gross › Deferred Tax Assets, Operating Loss Carryforwards, Components
us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic · last filed 2018-02-26
- 2017-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Domestic $6.00M.
- 2016-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Domestic $6.00M.
- 2015-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Domestic $4.90M.
- 2014-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Domestic $4.10M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards, Domestic |
|---|---|
| 2017-12-31 | $6.00M 10-K · filed 2018-02-26 |
| 2016-12-31 | $6.00M 10-K · filed 2017-03-06 |
| 2015-12-31 | $4.90M 10-K · filed 2016-03-11 |
| 2014-12-31 | $4.10M 10-K · filed 2015-03-12 |
| 2013-12-31 | $3.40M 10-K · filed 2014-03-14 |
| 2012-12-31 | $3.30M 10-K · filed 2013-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |